MOLECULAR PARTNERS SF 1 revenue breakdown overview

MOLECULAR PARTNERS SF 1 revenue for the last year amounted to 7.53 M EUR, the most of which — 7.57 M EUR — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 191.58 M EUR. The greatest contribution to the revenue figure was made by Switzerland — last year it brought MOLECULAR PARTNERS SF 1 7.57 M EUR, and the year before that — 181.82 M EUR.